Updated:
Bozhou Qiaocheng District Pharmaceutical Development Investment
Bozhou Qiaocheng District Pharmaceutical Development Investment is a government agency based in Bozhou, China. It focuses on pharmaceutical development...
Bozhou Qiaocheng District Pharmaceutical Development Investment
Bozhou Qiaocheng District Pharmaceutical Development Investment is a government agency based in Bozhou, China. It focuses on pharmaceutical development investments in Asia. The agency has committed to two funds.
General information
Firm type
Government / Public Body
Location
Region
Asia
Country
China
City
Bozhou
Corporate office
Qiaocheng District, Bozhou, Anhui, China
Sector focus
Frequently asked questions
What stages of investment does the firm target?
The firm operates across the full continuum: seed-stage capital for early Traditional Chinese Medicine processing technology, start-up equity for new branded formulations, and expansion-stage venture rounds for companies scaling Good Manufacturing Practice (GMP) certified production lines. The common thread is vertical integration of the local TCM supply chain, not stage-specific financial underwriting.
What makes the firm's capital structurally different from a typical healthcare venture fund?
The capital is patient, policy-anchored, and yields non-financial returns. It accepts infrastructure-linked horizons — waiting for manufacturing tenants to mature inside a district-owned industrial park — rather than targeting a fixed 7–10 year fund life. The return calculus includes regional GDP contribution, tax-base growth from GMP-certified factories, and trade volume through the government-controlled logistics center.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: